Active immunization with angiotensin I peptide analogue vaccines selectively reduces the presser effects of exogenous angiotensin I in conscious rats

British Journal of Pharmacology

Volumn 129, Issue 6, 2000, Pages 1178-1182

  Gardiner, S M ^a   Auton, T R ^b   Downham, M R ^b   Sharp, H L ^b   Kemp, P A ^a   March, J E ^a   Martin, H ^b   Morgan, P J ^b   Rushton, A ^b   Bennett, T ^a   Glover, J F ^b  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b Proteus Molecular Design Ltd   (United Kingdom)

Author keywords

Angiotensin vaccines; Angiotensinogen; Antibody titres; Pressor responses

Indexed keywords

ALDOSTERONE; ALUMINUM HYDROXIDE; ANGIOTENSIN DERIVATIVE; ANGIOTENSIN I; ANGIOTENSINOGEN; ANTIBODY; DRUG CARRIER; RENIN;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CROSS REACTION; DRUG CONJUGATION; MALE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VACCINATION;

EID: 0034018039     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703178     Document Type: Article

References (12)

1. BROWN, N.J. & VAUGHAN, D.E. (1998). Angiotensin-converting enzyme inhibitors. Circulation, 97, 1411-1420.
2. GARDINER, S.M., AUTON, T.R., DOWNHAM, M.R., SHARP, H.L., KEMP, P.A., MARCH, J.E., RUSHTON, A., BENNETT, T. & GLOVER, J.F. (1998). Effects of active immunization against angiotensin peptides on the pressor effects of exogenous angiotensin I (A1) in conscious rats. Br. J. Pharmacol., 124, 119P.
3. HORIUCHI, M., AKISHITA, M. & DZAU, V.J. (1999). Recent progress in angiotensin II type 2 receptor research in the cardiovascular system. Hypertension, 33, 613-621.
4. JOHNSTON, C.I., HUTCHINSON, J.S. & MENDELSOHN, F.A. (1970). Biological significance of renin angiotensin immunization. Circ. Res., 26-27(Suppl II): II-215-II-222.
5. MESSERLI, F.H., WEBER, A. & BRUNNER, H.R. (1996). Angiotensin II receptor inhibition. Arch. Intern. Med., 156, 1957-1965.
6. MICHEL, J.-B., GUETTIER, C., READE, R., SAYAH, S., CORVOL, P. & MÉNARD, J. ( 1989). Immunologic approaches to blockade of the renin-angiotensin system: a review. Am. Heart J., 117, 756-767.
7. OATES, H.F., STOKES, G.S., STOREY, B.G., GLOVER, R.G. & SNOW, B.F. (1974). Renal hypertension in rats immunized against angiotensin I and angiotensin II. J. Exp. Med., 139, 239-248.
8. SMITS, J., AUTON, T., SHARP, J., DOWNHAM, M., GLOVER, J. & JANSSEN, B. (1999). Anti-hypertensive properties of angiotensin immunotherapeutic in spontaneous hypertension in rats. FASEB J., 13, A483.
9. STROTH, U. & UNGER, T. (1999). The renin-angiotensin system and its receptors. J. Cardiovasc. Pharmacol., 33 (Suppl I): S21-S28.
10. SUNMAN, W. & SEVER, P.S. (1993). Non-angiotensin effects of angiotensin-converting enzyme inhibitors. Clin. Sci., 85, 661-670.
11. TARPEY, S.B., BENNETT, T., RANDALL, M.D. & GARDINER, S.M. (1998). Differential effects of endotoxaemia on presser and vasoconstrictor actions of angiotensin II and arginine vasopressin in conscious rats. Br. J. Pharmacol., 123, 1367-1374.
12. WALLER, J., GARDINER, S.M., JOSE, J. & BENNETT, T. (1995). Lack of effect of TNF antibodies on the cardiovascular sequelae of lipopolysaccharide infusion in conscious rats. Br. J. Pharmacol., 116, 2487-2495.